https://www.selleckchem.com/pr....oducts/enarodustat.h
After adjustment for several confounders (including Hcy), subjects in the highest quartile of plasma Cys had a 3.31 (95% CI, 1.32-8.30, p = 0.011) fold risk for CAD, compared with those in the lowest quartiles. Furthermore, plasma Cys levels (but not Hcy) tended to increase with the number of stenotic vessels (1VD 253 ± 64 μM; 2VD 262 ± 52 μM; 3VD 279 ± 57 μM, p = 0.129). Conclusion Hypercysteinemia revealed to be a better predictor of CAD than hyperhomocysteinemia. Moreover, plasma Cys showed to be a useful biomarker for CAD both i
Me gusta
Comentario
Compartir
